Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Booking Holdings Inc (BKNG) vs BIO-TECHNE Corp (TECH) Price & Performance

Booking Holdings IncTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Booking Holdings Inc vs BIO-TECHNE Corp — how do they compare? Booking Holdings Inc trades at $174.38 (market cap $135.49B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.10B). The key difference: Booking Holdings Inc is far larger — about 12.2× BIO-TECHNE Corp's market cap, and Booking Holdings Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.

BKNGTECH
Market Cap
$135.49B$11.10B
Sector
Consumer CyclicalHealth
52-Week High
$231.02$71.38
52-Week Low
$154.13$43.31
Enterprise Value
$138.41B$11.18B
Dividend Yield
0.92%0.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Booking Holdings Inc

Booking Holdings (BKNG) trades at $175.80, down 1.45% on the day, with a bearish technical signal but strong fundamentals including a 22.23% net income margin and consistent revenue growth. Recent earnings show mixed results with a Q1 2026 beat but a Q4 2025 miss, while analyst consensus remains strongly bullish with a $220.88 price target. The company maintains robust cash flow from operations at $9.41B for 2025 and continues to innovate in travel services, as highlighted by recent OpenTable initiatives.

The outlook for BKNG is positive based on solid profitability and growth prospects, though risks include high debt levels with a 64.02% debt-to-asset ratio and competitive pressures. Investment opportunity lies in its dominant market position and earnings potential, but investors should monitor execution risks and macroeconomic factors affecting travel demand.

BIO-TECHNE Corp

Bio-Techne (TECH) trades at $71.36, showing minimal daily movement (+0.08%) as the market digests Merck KGaA's $73 per share acquisition offer. The stock sits just 2.3% below the buyout price, with technical indicators showing bullish momentum. Fundamentally, the company maintains strong gross margins (64.96%) but faces declining net income margins (6.01% in 2025). Recent earnings show mixed results with one beat and two misses in the last four quarters.

The acquisition premium provides near-term upside potential, though shareholder litigation risks exist regarding deal fairness. Long-term investors face uncertainty about post-acquisition prospects, while current valuation metrics (P/E 101.94) appear stretched without the takeover scenario. The $73 offer price represents the primary catalyst, with downside risk to $50 if the deal fails.

Returns comparison

Trailing returns across standard periods

About Booking Holdings Inc

Booking is the world's largest online travel agency by revenue, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates a number of branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.

Read more on BKNG

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH